Bibliography
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999). Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine, 5(3), 347â350.
Authors
10
- Peter Klivenyi (first)
- Robert J. Ferrante (additional)
- Russell T. Matthews (additional)
- Mikhail B. Bogdanov (additional)
- Autumn M. Klein (additional)
- Ole A. Andreassen (additional)
- Gerald Mueller (additional)
- Marieke Wermer (additional)
- Rima Kaddurah-Daouk (additional)
- M. Flint Beal (additional)
References
23
Referenced
537
-
Wong, P.C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105–1116 (1995).
(
10.1016/0896-6273(95)90259-7
) / Neuron by PC Wong (1995) -
Gurney, M.E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772–1775 (1994).
(
10.1126/science.8209258
) / Science by ME Gurney (1994) -
Carri, M.T. et al. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 414, 365–368 (1997).
(
10.1016/S0014-5793(97)01051-X
) / FEBS Lett. by MT Carri (1997) -
Hemmer, W. & Wallimann, T. Functional aspects of creatine kinase in brain. Dev. Neurosci. 15, 249–260 (1993).
(
10.1159/000111342
) / Dev. Neurosci. by W Hemmer (1993) -
O'Gorman, E., Beutner, G., Wallimann, T. & Brdiczka, D. Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain. Biochim. Biophys. Acta 1276, 161–170 (1996).
(
10.1016/0005-2728(96)00074-6
) / Biochim. Biophys. Acta by E O'Gorman (1996) -
Gurney, M.E. et al. Antioxidants and inhibitors of glutamatergic transmission have therapeutic benefit in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147–157 (1996).
(
10.1002/ana.410390203
) / Ann. Neurol. by ME Gurney (1996) -
Dugan, L.L. et al. Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. USA 94, 9434–9439 (1997).
(
10.1073/pnas.94.17.9434
) / Proc. Natl. Acad. Sci. USA by LL Dugan (1997) -
Hottinger, A.F., Fine, E.G., Gurney, M.E., Zurn, A.D. & Aebischer, P. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic moouse model of familial amyotrophic lateral sclerosis. Eur. J. Neurosci. 9, 1548–1551 (1997).
(
10.1111/j.1460-9568.1997.tb01511.x
) / Eur. J. Neurosci. by AF Hottinger (1997) -
Kostic, V. et al. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 41, 497–504 (1997).
(
10.1002/ana.410410413
) / Ann. Neurol. by V Kostic (1997) -
Ferrante, R.J. et al. Increased 3-nitrotyrosine and oxidative damage in mice with a human Cu, Zn superoxide dismutase mutation. Ann. Neurol. 42, 326–334 (1997).
(
10.1002/ana.410420309
) / Ann. Neurol. by RJ Ferrante (1997) -
Bogdanov, M.B., Ramos, L.E., Xu, X. & Beal, M.F. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 71, 1321–1324 (1998).
(
10.1046/j.1471-4159.1998.71031321.x
) / J. Neurochem. by MB Bogdanov (1998) -
Sasaki, S., Maruyama, S., Yamane, K., Sakuma, H. & Takeishi, M. Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease. J. Neurol. Sci. 97, 233–240 (1990).
(
10.1016/0022-510X(90)90221-8
) / J. Neurol. Sci. by S Sasaki (1990) -
Siklos, L. et al. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann. Neurol. 39, 203–219 (1996).
(
10.1002/ana.410390210
) / Ann. Neurol. by L Siklos (1996) -
White, R.J. & Reynolds, I.J. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J. Neurosci. 16, 5688–5697 (1996).
(
10.1523/JNEUROSCI.16-18-05688.1996
) / J. Neurosci. by RJ White (1996) -
O'Gorman, E. et al. The role of creatine kinase inhibition of mitochondrial permeability transition. FEBS Lett. 414, 253–257 (1997).
(
10.1016/S0014-5793(97)01045-4
) / FEBS Lett. by E O'Gorman (1997) -
Sauter, A. & Rudin, M. Determination of creatine kinase parameters in rat brain by NMR magnetization transfer: correlation with brain function. J. Biol. Chem. 268, 13166–13171 (1993).
(
10.1016/S0021-9258(19)38633-8
) / J. Biol. Chem. by A Sauter (1993) -
Corbett, R.J.T. & Laptook, A.R. Age-related changes in swine brain creatine kinase-catalyzed 31P exchange measured in vivo using 31P NMR magnetization transfer. J. Cereb. Blood Flow Metab. 14, 1070–1077 (1994).
(
10.1038/jcbfm.1994.140
) / J. Cereb. Blood Flow Metab. by RJT Corbett (1994) -
Xu, C.J. et al. Phosphocreatine-dependent glutamate uptake by synaptic vesicles. J. Biol. Chem. 271, 13435–13440 (1996).
(
10.1074/jbc.271.23.13435
) / J. Biol. Chem. by CJ Xu (1996) -
Rothstein, J.D., M., V.K., Levey, A.I., Martin, L. & Kuncl, R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73–84 (1995).
(
10.1002/ana.410380114
) / Ann. Neurol. by JD Rothstein (1995) -
Sipila, I., Rapola, J., Simell, O. & Vannas, A. Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N. Engl. J. Med. 304, 867–870 (1981).
(
10.1056/NEJM198104093041503
) / N. Engl. J. Med. by I Sipila (1981) -
Blanchard, V., Raisman-Vozari, R., Vyas, S., Michel, P.P., Javoy-Agid, F. & Uhl, G. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of rat mesencephalon. Molec. Brain Res. 22, 29–40 (1994).
(
10.1016/0169-328X(94)90029-9
) / Molec. Brain Res. by V Blanchard (1994) -
Matthews, R.T. et al. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci. 18, 156–163 (1998).
(
10.1523/JNEUROSCI.18-01-00156.1998
) / J. Neurosci. by RT Matthews (1998) -
Bogdanov, M.B., Ramos, L.E., Xu, X. & Beal, M.F. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 71, 1321–1324 (1998).
(
10.1046/j.1471-4159.1998.71031321.x
) / J. Neurochem. by MB Bogdanov (1998)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 4:34 a.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 6:13 p.m.) |
Indexed | 1 day, 4 hours ago (Aug. 26, 2025, 2:37 a.m.) |
Issued | 26 years, 5 months ago (March 1, 1999) |
Published | 26 years, 5 months ago (March 1, 1999) |
Published Print | 26 years, 5 months ago (March 1, 1999) |
@article{Klivenyi_1999, title={Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis}, volume={5}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/6568}, DOI={10.1038/6568}, number={3}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Klivenyi, Peter and Ferrante, Robert J. and Matthews, Russell T. and Bogdanov, Mikhail B. and Klein, Autumn M. and Andreassen, Ole A. and Mueller, Gerald and Wermer, Marieke and Kaddurah-Daouk, Rima and Beal, M. Flint}, year={1999}, month=mar, pages={347–350} }